J clin oncol 2005 23 6549-55

Author: bsso

August undefined, 2024

WebYou need to enable JavaScript to run this app. DocGuide. You need to enable JavaScript to run this app. WebMay 28, 2024 · Introduction. The US Food and Drug Administration (FDA) approves cancer drugs based on (1) overall survival (OS) or patient reported outcomes, (2) progression-free survival, ie, the time until cancer recurs or worsens, or (3) response rate (RR), ie, the percent of patients experiencing tumor shrinkage. 1,2 Response rate and complete response rate …

Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J …

WebJan 29, 2014 · J Clin Oncol. 2005. 23:6549-55. Ronnen EA, Kondagunta GV, Bacik J, et al. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. J Clin … WebFeb 20, 2024 · Favorable responses were achieved by 80%, with complete responses in 23 patients (77%) and a partial response with marker normalization in one patient. At a median follow-up of 33 months, 22 (73%) of the favorable … hampton house alderholt

Chemotherapy for Extracranial Germ Cell Tumours in Paediatric ...

WebNov 20, 2014 · Masses larger than 3 cm carry a higher risk of containing seminoma, and positron-emission tomographic imaging is sometimes performed 6 weeks after … WebPubMed WebJ Clin Oncol. 2005;23(19):4338–4346. 23. Villa E, Ferretti I, Grottola A, et al. Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors. ... Lancet Oncol. 2013;14(1):55–63. 38. The ASCO Post. FDA expands approved use of regorafenib for hepatocellular carcinoma. 2024 Apr 27 ... hampton hotel winnipeg

Optimal therapy for patients with hepatocellular carcinoma and ...

High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic

WebJ Clin Oncol 23:6549-6555. © 2005 by American Society of Clinical Oncology INTRODUCTION Between 70% and 80% of patients with ad-vanced, metastatic germ cell … WebThis invention concerns methods of treating a patient diagnosed with glioblastoma comprising administering to said patient a therapy comprising an effective amount of an anti-VEGF antibody and a chemotherapeutic. hampton house at the beach patongaWebIntroduction. Multiple myeloma is a hematological malignancy characterized by neoplastic proliferation of clonal plasma cells. 1 Several landmark advances have been made in the … burt martin houston tx

"WebJan 28, 2024 · J Am Geriatr Soc 2007; 55: 993–1000. 21. Jang RW, Burman D, Swami N et al. Impact of an oncology palliative care clinic on access to home care services. Am J Hosp Palliat Care 2013; 30: 425–431. ... J Clin Oncol 2005; 23: 6865–6872. 24. Yoong J, Park ER, Greer JA et al. Early palliative care in advanced lung cancer: a qualitative study ... " - J clin oncol 2005 23 6549-55

J clin oncol 2005 23 6549-55

Time-to-Treatment-Failure and Related Outcomes among 1000

WebJan 1, 2009 · Request PDF On Jan 1, 2009, J.S. Parker and others published J Clin Oncol. Find, read and cite all the research you need on ResearchGate WebApr 25, 2012 · XmAb2513 is a modified anti-CD30 antibody with increased binding affinity to the Fc receptor. In vitro data showed more potent and efficacious cell killing than first-generation anti-CD30 monoclonal antibodies XDA-060 and SGN-30. In clinical trials, only phase I data are available.

Did you know?

WebOct 24, 2024 · J Clin Oncol. 1998;16(7):2500-4. Kondagunta GV et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol. 2005;23(27):6549-55. WebJan 29, 2024 · J Clin Oncol. 2005. 23:6549-55. Einhorn LH, Williams SD, Chamness A, et al. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J …

WebApr 8, 2024 · 55. Headley JA, Ownby KK, John Lauri D. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. Oncol Nurs Forum 2004; 31(5): 977–983. Crossref. PubMed. ... J Clin Oncol 2005; 23(4): 899–909. Crossref. PubMed. ISI. Google Scholar. 59. WebSep 21, 2016 · Patients eligible to participate in the phase III study had histologically confirmed, bidimensionally measurable, metastatic CRC. Patients had to be at least 18 years old, have an Eastern Cooperative Oncology Group (ECOG) performance status 13 of 0 or 1, have a life expectancy greater than 3 months, and have adequate hematologic, hepatic, …

WebMay 28, 2024 · J Clin Oncol (2005) 23:6549–55. doi: 10.1200/JCO.2005.19.638. PubMed Abstract CrossRef Full Text Google Scholar. 33. Motzer RJ, Nichols CJ, Margolin KA, Bacik J, Richardson PG, Vogelzang NJ, et al. Phase III Randomized Trial of Conventional-Dose Chemotherapy With or Without High-Dose Chemotherapy and Autologous Hematopoietic … WebJul 20, 2005 · 10.1200/JCO.2005.07.757 Abstract Purpose: To compare long-term survival in patients with locally advanced or metastatic transitional cell carcinoma (TCC) of the urothelium treated with gemcitabine/cisplatin (GC) or methotrexate/vinblastine/doxorubicin/cisplatin (MVAC). Patients and methods:

WebSep 21, 2016 · Journal of Clinical Oncology > List of Issues > Volume 23, Issue 27 > Genitourinary Cancer OPTIONS & TOOLS Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors G. Varuni Kondagunta , Jennifer Bacik , Alessia Donadio , Dean Bajorin , …

WebApr 27, 2024 · We systematically analyzed germ cell therapy trials with the goal of providing evidence for the efficacy of HDCT in the treatment of GCC. Our goal was to identify patient characteristics and... burt mashburn mdWebJan 10, 2024 · Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy. … burt mattesonWebApr 20, 2005 · 10.1200/JCO.2005.09.050 Abstract Purpose: This is the first study in which the NK(1)-receptor antagonist, aprepitant (APR), was evaluated for the prevention of chemotherapy-induced nausea and vomiting (CINV) with moderately emetogenic chemotherapy. Patients and methods: burt mashburn obgynWebThe toxic effects of high-dose chemotherapy were primarily myelosuppression, mucositis, nausea, vomiting, dehydration, peripheral neuropathy, and otologic abnormalities. 8 There … hampton house apartments ridgeland msWebJ Clin Oncol. 2005 Sep 20;23(27):6549-55. link to original article contains dosing details in manuscript PubMed; Kurobe M, Kawai K, Oikawa T, Ichioka D, Kandori S, Takaoka E, Kojima T, Joraku A, Suetomi T, Miyazaki J, Nishiyama H. Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor. ... burt martinWebSearch worldwide, life-sciences literature Search. Advanced Search Coronavirus articles and preprints Search examples: "breast cancer" Smith J burt matticeWebJul 27, 2009 · J Clin Oncol. 2005; 23 (abstr).: 624s Google Scholar Definitive estimates are now available for all endpoints; median follow-up for all patients was 22·5 months (range 0·9–125·1) and for those still alive at the final analysis was 69·3 months (6·2–125·1). hampton house apartments cleveland ohio